Gene transfer of constitutively active caspase-3 induces apoptosis in a human hepatoma cell line

Journal of Gene Medicine

Volumn 7, Issue 1, 2005, Pages 30-38

  Cam, Laurence ^a   Boucquey, Antoine ^a   Coulomb L'hermine, Aurore ^a,b   Weber, Anne ^a   Horellou, Philippe ^a  

^a INSERM   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Apoptosis; Caspases; Gene therapy; Human hepatocarcinoma; Retroviral vectors

Indexed keywords

ACRIDINE ORANGE; CASPASE 3; DNA FRAGMENT; GONADORELIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RECOMBINANT CASPASE 3; RECOMBINANT ENZYME; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS RNA;

APOPTOSIS; ARTICLE; CELL STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE REARRANGEMENT; GENE TRANSFER; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOLECULAR CLONING; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL ANALYSIS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS TITRATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASES; CELL LINE, TUMOR; COLLAGEN TYPE XI; DNA FRAGMENTATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; KINETICS; OPERON; POLY(ADP-RIBOSE) POLYMERASES; RECOMBINANT PROTEINS; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 12744263021     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.636     Document Type: Article

References (26)

1. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17: 2941-2953.
2. Stennicke HR, Jurgensmeier JM, Shin H, et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998; 273: 27 084-27 090.
3. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489.
4. Devarajan E, Sahin AA, Chen JS, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 2002; 21: 8843-8851.
5. Fujikawa K, Shiraki K, Sugimoto K, et al. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma. Anticancer Res 2000; 20: 1927-1932.
6. Shariat SF, Desai S, Song W, et al. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. Cancer Res 2001; 61: 2562-2571.
7. Friedrich K, Wieder T, Von Haefen C, et al. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene 2001; 20: 2749-2760.
8. Yamabe K, Shimizu S, Ito T, et al. Cancer gene therapy using a pro-apoptotic gene, caspase-3. Gene Ther 1999; 6: 1952-1959.
9. Srinivasula SM, Ahmad M, MacFarlane M, et al. Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J Biol Chem 1998; 273: 10 107-10 111.
10. Suzuki Y, Nakabayashi Y, Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its antiapoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A 2001; 98: 8662-8667.
11. Cosset FL, Takeuchi Y, Battini JL, et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
12. Nguyen TH, Loux N, Vons C, et al. Retroviral-mediated gene transfer into human hepatocytes and improved selectivity of retroviral vectors for hepatocarcinoma cells by genetic engineering of the amphotropic envelope protein. Cancer Gene Ther 2003; 10: 840-849.
13. Stennicke HR, Salvesen GS. Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem 1997; 272: 25 719-25 723.
14. Mpoke SS, Wolfe J. Differential staining of apoptotic nuclei in living cells: application to macronuclear elimination in Tetrahymena. J Histochem Cytochem 1997; 45: 675-683.
15. Iolascon A, Borriello A, Giordani L, et al. Caspase 3 and 8 deficiency in human neuroblastoma. Cancer Genet Cytogenet 2003; 146: 41-47.
16. Janicke RU, Sprengart ML, Wati MR, et al. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998; 273: 9357-9360.
17. Kolenko V, Uzzo RG, Bukowski R, et al. Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res 1999; 59: 2838-2842.
18. Hsia JY, Chen CY, Chen JT, et al. Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. Eur J Surg Oncol 2003; 29: 44-48.
19. Caruso M, Panis Y, Gagandeep S, et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A 1993; 90: 7024-7028.
20. Kondo S, Tanaka Y, Kondo Y, et al. Retroviral transfer of CPP32beta gene into malignant gliomas in vitro and in vivo. Cancer Res 1998; 58: 962-967.
21. Shinoura N, Muramatsu Y, Yoshida Y, et al. Adenovirus-mediated transfer of caspase-3 with Fas ligand induces drastic apoptosis in U-373MG glioma cells. Exp Cell Res 2000; 256: 423-433.
22. Pollett JB, Zhu YX, Gandhi S, et al. RU486-inducible retrovirus-mediated caspase-3 overexpression is cytotoxic to bcl-xL-expressing myeloma cells in vitro and in vivo. Mol Ther 2003; 8: 230-237.
23. Ansorena E, Garcia-Trevijano ER, Martinez-Chantar ML, et al. S-Adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology 2002; 35: 274-280.
24. Deveraux QL, Reed JC. IAP family proteins - suppressors of apoptosis. Genes Dev 1999; 13: 239-252.
25. Ido A, Nakata K, Kato Y, et al. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res 1995; 55: 3105-3109.
26. Komata T, Kondo Y, Kanzawa T, et al. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res 2001; 61: 5796-5802.